| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |